Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered - Allarity Therapeutics (NASDAQ:ALLR)

Benzinga

2024-06-25 00:28

Allarity Therapeutics shares are trading lower by 27.6% during Monday's session. The company announced that it received a noncompliance letter from the Nasdaq.

　　Allarity Therapeutics IncALLR shares are trading lower by 28.40% to $0.32 during Mondays session after the company announced it received a noncompliance letter from the Nasdaq.

　　On June 18, Allarity received a notice from Nasdaq indicating the company failed to meet the requirement of maintaining a minimum bid price of $1 per share for 30 consecutive business days. Allarity plans to request a hearing to appeal for continued listing.

　　This request will temporarily prevent the suspension and delisting of its stock until the hearing concludes. However, there is no guarantee that the appeal will be successful and that the companys stock will continue to be listed on the Nasdaq Capital Market.

　　According to data from Benzinga Pro, ALLR has a 52-week high of $269.80 and a 52-week low of $0.32.

Disclaimer:The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.

Latest News

Promoting the development of lithium and sodium in the new energy industry